Canada markets open in 7 hours 3 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6900+0.0400 (+1.10%)
At close: 04:00PM EDT
3.7800 +0.09 (+2.44%)
After hours: 06:45PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 302.17M
Enterprise Value 158.41M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.23
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.73

Trading Information

Stock Price History

Beta (5Y Monthly) 0.57
52-Week Change 3-56.07%
S&P500 52-Week Change 323.57%
52 Week High 310.4500
52 Week Low 33.2500
50-Day Moving Average 34.6077
200-Day Moving Average 36.4447

Share Statistics

Avg Vol (3 month) 31.32M
Avg Vol (10 day) 31.41M
Shares Outstanding 582.11M
Implied Shares Outstanding 682.11M
Float 879.52M
% Held by Insiders 13.14%
% Held by Institutions 132.01%
Shares Short (Apr 15, 2024) 422.01M
Short Ratio (Apr 15, 2024) 415.51
Short % of Float (Apr 15, 2024) 427.68%
Short % of Shares Outstanding (Apr 15, 2024) 426.80%
Shares Short (prior month Mar 15, 2024) 420M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Oct 07, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 30, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-20.70%
Return on Equity (ttm)-31.88%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-43.16M
Diluted EPS (ttm)-0.5400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)143.76M
Total Cash Per Share (mrq)1.75
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)11.85
Book Value Per Share (mrq)1.65

Cash Flow Statement

Operating Cash Flow (ttm)-29.31M
Levered Free Cash Flow (ttm)-17.68M